Infinity Pharmaceuticals Cash End of Year Trend

Infinity Pharmaceuticals Inc -- USA Stock  

USD 2.43  0.11  4.33%

This module enables investors to look at Infinity Pharmaceuticals various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Cost of Revenue of 32.5 M, Gross Profit of 6 M or Interest Expense of 1.6 M, but also many exotic indicators such as Long Term Debt to Equity of 0.2339, PPandE Turnover of 5.4358 or Receivables Turnover of 1 K. This module is a perfect complement to use when analyzing Infinity Pharmaceuticals Valuation or Volatility. It can also complement various Infinity Pharmaceuticals Technical models. Please also check analysis of Infinity Pharmaceuticals Correlation with competitors.
Showing smoothed Cash End of Year of Infinity Pharmaceuticals Inc with missing and latest data points interpolated.
Cash End of Year  10 Years Trend  
Slightly volatile
 Cash End of Year 

Infinity Pharmaceuticals Cash End of Year Over Time

2016-12-31  188,170,000 
2017-12-31  188,170,000 
2018-12-31  221,376,471 

Other Fundumenentals


Regression Statistics

Arithmetic Mean  112,380,974
Geometric Mean  65,247,166
Coefficient Of Variation  90.34
Mean Deviation  91,499,635
Median  68,114,000
Standard Deviation  101,524,321
Range  291,117,771
R Value  0.81
R Squared  0.65
Significance  0.00082948
Slope  21,067,143

Currently Trending

Sold over 70 shares of
a day ago ago
Traded for 37.94
Purchased over 40 shares of
a day ago ago
Traded for 61.5945
Sold over 200 shares of
a day ago ago
Traded for 11.15